{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:58Z","timestamp":1761182998050,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jiac.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:22:10Z","timestamp":1572744130000},"page":"285-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report"],"prefix":"10.1016","volume":"26","author":[{"given":"Yoshiaki","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohkan","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.10.005_bib1","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"278","article-title":"Cephalosporins","author":"Craig","year":"2015"},{"author":"Ceftriaxone","key":"10.1016\/j.jiac.2019.10.005_bib2"},{"year":"2016","series-title":"The Sanford guide to antimicrobial therapy 2016","author":"Gilbert","key":"10.1016\/j.jiac.2019.10.005_bib3"},{"key":"10.1016\/j.jiac.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.25.4.438","article-title":"Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment","volume":"25","author":"Patel","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2017.03.018","article-title":"Cefepime-induced encephalopathy in end-stage renal disease patients","volume":"376","author":"Nakagawa","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jiac.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/00365548.2013.878032","article-title":"Cefepime-induced encephalopathy in patients with haematological malignancies: clinical features and risk factors","volume":"46","author":"Ugai","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcma.2011.01.017","article-title":"Cefepime-related encephalopathy in peritoneal dialysis patients","volume":"74","author":"Lin","year":"2011","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.jiac.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MAJ.0b013e3181ec063b","article-title":"Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease","volume":"340","author":"Sato","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jiac.2019.10.005_bib9","article-title":"Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient","volume":"2014","author":"Safadi","year":"2014","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.jiac.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ekir.2017.03.009","article-title":"Three cases of hemodialysis patients receiving high-dose ceftriaxone: serum concentrations and its neurotoxicity","volume":"2","author":"Inoue","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jiac.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/jcph.317","article-title":"Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis","volume":"54","author":"Zhao","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"year":"2004","series-title":"Handbook of basic pharmacokinetics including clinical applications","author":"Ritschel","key":"10.1016\/j.jiac.2019.10.005_bib12"},{"year":"2015","series-title":"Rang & Dale's pharmacology","key":"10.1016\/j.jiac.2019.10.005_bib13"},{"key":"10.1016\/j.jiac.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1023\/A:1005661117739","article-title":"Antipyrine clearance and metabolite formation in primary biliary cirrhosis","volume":"46","author":"Jorquera","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jiac.2019.10.005_bib16","series-title":"Bradley's neurology in clinical practice","first-page":"348","article-title":"Electroencephalography and evoked potentials","author":"Hahn","year":"2016"},{"key":"10.1016\/j.jiac.2019.10.005_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jiac.2019.10.005_bib18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2169\/internalmedicine.1785-18","article-title":"Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient","volume":"58","author":"Suzuki","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3346\/jkms.2012.27.9.1120","article-title":"Ceftriaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review","volume":"27","author":"Kim","year":"2012","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jiac.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000472148","article-title":"Choreoathetosis is a possible adverse event of a commonly used antibiotic","volume":"9","author":"Sathirapanya","year":"2017","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jiac.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/AAC.22.5.816","article-title":"Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults","volume":"22","author":"Pollock","year":"1982","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:12Z","timestamp":1761159552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19303058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1341321X19303058"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.005","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}